Nov 07, 2023
Keros Therapeutics to Present at Upcoming Healthcare Conferences
Nov 06, 2023
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results
Nov 02, 2023
Keros Therapeutics to Present at the 65th American Society of Hematology Annual Meeting and Exposition
Oct 04, 2023
Keros Therapeutics Presents Preclinical Data from its KER-065 Program at the 28th International Annual Congress of the World Muscle Society
Sep 05, 2023
Keros Therapeutics to Present at Upcoming Healthcare Conferences
Aug 07, 2023
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
Jul 27, 2023
Corrected: Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
Jul 24, 2023
Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
Jun 12, 2023
Keros Therapeutics Announces Update to Participation at the Goldman Sachs 44th Annual Global Healthcare Conference
Jun 09, 2023
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual Congress of the European Hematology Association
Displaying 1 - 10 of 18